Prelude Therapeutics
PRLD
PRLD
60 hedge funds and large institutions have $113M invested in Prelude Therapeutics in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 24 increasing their positions, 16 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
36% less capital invested
Capital invested by funds: $176M → $113M (-$63.1M)
75% less call options, than puts
Call options by funds: $1K | Put options by funds: $4K
Holders
60
Holding in Top 10
–
Calls
$1K
Puts
$4K
Top Buyers
| 1 | +$1.08M | |
| 2 | +$813K | |
| 3 | +$647K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$274K |
| 5 |
TD Asset Management
Toronto,
Ontario, Canada
|
+$248K |
Top Sellers
| 1 | -$13M | |
| 2 | -$2.5M | |
| 3 | -$231K | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$148K |
| 5 |
Renaissance Technologies
New York
|
-$136K |